USPTO serial 79288636
MIRA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 3, 2021
- Examiner
- NADELMAN, ANDREA KOYNER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MIRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ursula B. Day
Ursula B. Day Law Firm of Ursula B. Day35 West 35th StreetSuite 900New York, NY 10001Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for diagnostic use, namely, laboratory chemicals in the nature of nucleic acid amplification reagents used for the detection of nucleic acids of pathogens for in vitro diagnostic use for scientific purposes, chemical preparations for scientific diagnostic purposes; chemical reagents for chemical analyses for non medical purposes; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; chemical reagents for use in analytical tests, other than for medical or veterinary use; chemical reagents for laboratory use, other than for medical or veterinary use; nucleic acid for use in nucleic acid amplification processes other than for medical or veterinary use; chemicals for use in performing nucleic acid polymerase chain reactions for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; nucleic acid amplification reagents other than for medical or veterinary use | ACTIVE | — |
| 005 | Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical use; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; reagents for medical use; chemical preparations for testing blood for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical purposes for detecting the presence of pathogenic bacteria, viruses, fungi and parasites; diagnostic preparations and materials, namely, diagnostic preparations for veterinary purposes and diagnostic preparations for medical purposes; clinical diagnostic reagents for medical purposes | ACTIVE | — |
| 009 | Computer hardware and recorded and downloadable software for diagnostic purposes, namely, for operating and configuring processing apparatus for diagnostic tests and displaying apparatus for diagnostic results in relation to infectious diseases; mobile apps for diagnostic purposes, namely, downloadable mobile applications for use in data management of diagnostic results and in management of diagnostic apparatus in relation to infectious diseases; laboratory apparatus and instruments for diagnostic purposes, namely, diagnostic apparatus for the detection of pathogens for laboratory use; laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; all the aforementioned goods in relation to diagnostic purposes for infectious diseases, and none used in relation to immunochemical testing but including immunoassay technologies | ACTIVE | — |
| 010 | Apparatus, instruments and equipment for diagnostic purposes, namely, diagnostic apparatus for the detection of pathogenic bacteria, viruses, fungi and parasites for medical purposes; automatic analyzers for medical diagnosis, namely, nucleic acid amplification and detection apparatus; analyzers for bacterial identification for medical purposes; apparatus for analyzing bacteria in biological samples for medical use; automated analyzers for body fluids for medical use in the nature of medical diagnostic instruments for the analysis of body fluids; automated analyzers for foreign matter contained in body fluids, namely, pathogenic bacteria, viruses, fungi and parasites contained in body fluids for medical use in the nature of medical diagnostic instruments for the analysis of foreign matter contained in body fluids, namely, of pathogenic bacteria, viruses, fungi and parasites contained in body fluids; electronic analyzers for medical purposes, namely, apparatus for nucleic acid amplification and detection for medical diagnostics; photometric and fluorescence-based analyzers of nucleic acid amplification reactions for medical use; physical analyzers of pathogenic bacteria, viruses, fungi and parasites for medical use; genetic testing apparatus for medical purposes in the nature of apparatus for nucleic acid testing for medical purposes; blood testing apparatus; apparatus for blood analysis for medical use; automatic analyzers in the nature of nucleic acid analyzers for medical diagnostic uses; diagnostic apparatus for medical purposes, namely, for testing for pathogenic bacteria, viruses, fungi and parasites as well as their resistances; analyzers for medical use, namely, medical instruments for analyzing and identifying pathogenic bacteria, viruses, fungi and parasites; diagnostic test kits comprised of enzymes, oligonucleotides and further nucleic acid amplification and detection reagents for detecting the existence of multi-resistant germs in human body fluids and of blood disorders; all the aforementioned goods in relation to diagnostic purposes for infectious diseases and not including brushes related goods nor used in relation to immunochemical testing but including immunoassay technologies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Spindiag GmbH
- Other trademarks owned by Spindiag GmbH
- Other trademarks owned by Spindiag GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named MIRA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 3, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 29, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 6, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 6, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 3, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 3, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 30, 2021 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| May 19, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Apr 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 18, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 31, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 31, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 31, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 17, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 17, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 17, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 17, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 17, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 23, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 22, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 3, 2021 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Feb 3, 2021 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jan 3, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 5, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 5, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 5, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 5, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 5, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 5, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 5, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 21, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 16, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 15, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 13, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |